Results 21 to 30 of about 69,108 (161)
International Journal of Cardiology: Heart & Vasculature, 2020 Patients receiving psychiatric medication, like the antipsychotic drug haloperidol, are at an increased risk of sudden cardiac death (SCD). Haloperidol blocks the cardiac rapidly-activating delayed rectifier potassium current, thereby increasing ...
Stefan M. Sattler +9 more
doaj +1 more source
Haloperidol Attenuates Lung Endothelial Cell Permeability In Vitro and In Vivo
Cells, 2021 We previously reported that claudin-5, a tight junctional protein, mediates lung vascular permeability in a murine model of acute lung injury (ALI) induced by lipopolysaccharide (LPS).
Marco A. Colamonici +3 more
doaj +1 more source
Retrospective Study of Midazolam Protocol for Prehospital Behavioral Emergencies [PDF]
, 2020 Introduction: Agitated patients in the prehospital setting pose challenges for both patient care and emergency medical services (EMS) provider safety. Midazolam is frequently used to control agitation in the emergency department setting; however, limited
Huebinger, Ryan M. +7 more
core +1 more source
IBRO Neuroscience Reports, 2023 Antipsychotic treatment is vital for patients with schizophrenia even in the perinatal period, but the impact at the molecular biological level on offspring is unclear.
Hiroshi Kumon +5 more
doaj +1 more source
Effects of haloperidol and atypical neuroleptics on psychomotor performance and driving ability in schizophrenic patients - Results from an experimental study [PDF]
, 2003 The influence of antipsychotic treatment on the neuropsychological and psychomotor performance of schizophrenic patients is still a subject of investigation.
Kagerer, S. +3 more
core +1 more source
Cell & Bioscience, 2011 Haloperidol is an antipsychotic drug that exerts its' antipsychotic effects by inhibiting dopaminergic neurons. Although the exact pathophysiology of haloperidol extrapyramidal symptoms are not known, the role of reactive oxygen species in inducing ...
Perera Joachim +4 more
doaj +1 more source
Relapse in patients with schizophrenia: a comparison between risperidone and haloperidol [PDF]
Brazilian Journal of Psychiatry, 2003 OBJECTIVES: To compare rates of rehospitalization and time to relapse in risperidone vs. haloperidol-treated schizophrenic patients discharged from the hospital. METHODS: Randomized controlled trial comparing risperidone and haloperidol regarding relapse
Eduardo Pondé de Sena +4 more
doaj +1 more source
Antipsychotic Response in the First Week Predicts Later Efficacy [PDF]
, 2012 Background and Aims: Time of onset of antipsychotic action is still a debated matter. We aimed to replicate and extend previous findings that early response can predict subsequent non-response.
Andrisano, Costanza +7 more
core +1 more source
Propionate Protects Haloperidol-Induced Neurite Lesions Mediated by Neuropeptide Y
Frontiers in Neuroscience, 2018 Haloperidol is a commonly used antipsychotic drug for treating schizophrenia. Clinical imaging studies have found that haloperidol can cause volume loss of human brain tissue, which is supported by animal studies showing that haloperidol reduces the ...
Minmin Hu +9 more
doaj +1 more source
Clozapine as add-on medication in the maintenance treatment of bipolar and schizoaffective disorders - A case series [PDF]
, 2002 Atypical neuroleptics are increasingly used in the treatment of bipolar and schizoaffective disorders. Currently, numerous controlled short-term studies are available for clozapine, olanzapine, risperidone or quetiapine, but long-term data are still ...
Amann, B. +5 more
core +1 more source